SmithKline Beckman
E407057
SmithKline Beckman was a major American pharmaceutical and diagnostics company formed by the merger of SmithKline and Beckman Instruments, later becoming part of GlaxoSmithKline (GSK).
All labels observed (1)
| Label | Occurrences |
|---|---|
| SmithKline Beckman canonical | 2 |
Statements (30)
| Predicate | Object |
|---|---|
| instanceOf |
diagnostics company
ⓘ
pharmaceutical company ⓘ public company ⓘ |
| abbreviation | SKB ⓘ |
| areaServed | worldwide ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| fate | merged into SmithKline Beecham ⓘ |
| formedByMergerOf |
Beckman Instruments
ⓘ
Smith, Kline & French ⓘ
surface form:
SmithKline
|
| headquartersCountry |
United States of America
ⓘ
surface form:
United States
|
| headquartersLocation |
Philadelphia
ⓘ
surface form:
Philadelphia, Pennsylvania
|
| historicalSignificance | major American pharmaceutical and diagnostics company ⓘ |
| industry |
medical diagnostics
ⓘ
pharmaceuticals ⓘ |
| mergedInto |
GlaxoSmithKline
ⓘ
surface form:
SmithKline Beecham
|
| notableProduct |
H2 receptor antagonist cimetidine
ⓘ
surface form:
Tagamet
pharmaceutical diagnostics systems ⓘ |
| operatedInSector |
healthcare
ⓘ
life sciences ⓘ |
| origin | merger of a drug company and an instruments company ⓘ |
| parentCompany |
GlaxoSmithKline
ⓘ
surface form:
SmithKline Beecham
|
| partOf | GlaxoSmithKline ⓘ |
| predecessor |
Beckman Instruments
ⓘ
Smith, Kline & French ⓘ
surface form:
SmithKline
|
| productType |
diagnostic instruments
ⓘ
laboratory equipment ⓘ prescription drugs ⓘ |
| successor |
GlaxoSmithKline
ⓘ
surface form:
SmithKline Beecham
|
| successorInPharmaceuticalBusiness | GlaxoSmithKline ⓘ |
| ultimateParentCompany | GlaxoSmithKline ⓘ |
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.